Citing Shutdown, FDA Postpones Advisory Meeting on Allergy Vaccine

Drug Industry Daily
A A
Citing the ongoing government shutdown, the FDA has postponed an advisory committee meeting scheduled for November, a precarious bellwether for drugmakers worried about how the political impasse will affect pending applications.

To View This Article:

Login

Subscribe To Drug Industry Daily